article thumbnail

Introducing the new NIHR National Patient Recruitment Centres

pharmaphorum

One of the Sector Deal 2 commitments within the Government’s Life Sciences Industrial Strategy, the NPRCs are the first NIHR-funded research infrastructure that is 100% dedicated to delivering commercial research.

article thumbnail

Introducing the new NHS Patient Recruitment Centres

pharmaphorum

One of the Sector Deal 2 commitments within the Government’s Life Sciences Industrial Strategy, the NPRCs are the first NIHR-funded research infrastructure that is 100% dedicated to delivering commercial research.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

“Nothing scares us” – Ukraine’s clinical research sector begins fearless recovery

Drug Discovery World

It was a subject of intense ethical debate whether life sciences companies should join other industries in leveraging sanctions against Russia, though many issued statements to say they had ceased clinical trial activity in the country. Russia invaded Ukraine on February 24, 2022.

article thumbnail

Cardiac Biomarkers in Cardiovascular Clinical Trials: Caveats and Considerations

XTalks

This is a part of the precision cardiology approach and could lead to their use as prognostic indicators. Liz Moore, DNP, advanced clinical nurse practitioner at Medpace, says that until the future of cardiac biomarkers arrives, CV clinical trials will have to continue to include and learn from the current markers.

article thumbnail

Importance of diversity in pharma and clinical trials

pharmaphorum

A notable example is the relative lack of Black participants in cardiology trials. For example, instead of only engaging specialists, general practitioners, nurses, pharmacists, and even patients can be engaged in the same or in a parallel advisory board. Virtual and hybrid meetings also allow more diverse voices to be heard.